Antihypertensive and antiremodeling effects of Rho kinase inhibition via activation of ACE2 pathway: support from studies in a human model opposite to hypertension

J Hypertens. 2011 Aug;29(8):1660-1. doi: 10.1097/HJH.0b013e328348f05a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Hypertension / metabolism*
  • Male
  • Peptidyl-Dipeptidase A / metabolism*
  • rho-Associated Kinases / antagonists & inhibitors*

Substances

  • rho-Associated Kinases
  • Peptidyl-Dipeptidase A